—Oral administration—As adjunctive therapy can reduce glucocorticoid daily requirement—In coadministration with aromatase inhibitors can prevent premature epiphyseal maturation with good effect on final height in children with CAH. This evidence concerns the gene CYP19A1 and congenital adrenal hyperplasia.